Results 21 to 30 of about 26,425 (258)
Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
Vaccines, 2021 In this study, we generated the HEV virus-like particle (VLP) vaccine expressing 239 amino acids (367–605 aa) of the HEV-3 ORF2 using the baculovirus expression system.
Hyeon-Jeong Go +11 more
doaj +1 more source
Vaccines, 2021 In this study, our goal was to utilize the extracellular domain matrix-2 protein virus-like particle (M2e VLP) that has been found to be highly conserved amongst all strains of influenza and could serve as a potential vaccine candidate against influenza.
Kimberly Braz Gomes +4 more
doaj +1 more source
Vaccines, 2020 Virus-like particles (VLPs) have emerged as promising vaccine candidates against foot-and-mouth disease (FMD). However, such vaccines provide a relatively low level of protection against FMD virus (FMDV) because of their poor immunogenicity.
Woo Sik Kim +5 more
doaj +1 more source
Dry Formulation of Virus-Like Particles in Electrospun Nanofibers
Vaccines, 2021 Biologics can be combined with liquid polymer materials and electrospun to produce a dry nanofibrous scaffold. Unlike spray-drying and freeze-drying, electrospinning minimizes the physiological stress on sensitive materials, and nanofiber mat properties ...
Sasheen Dowlath +6 more
doaj +1 more source
VLP-RBD vaccine protects mice from SARS-CoV-2 infection in vivo.
, 2021 Mice were immunized with VLP-RBD vaccine, RBD vaccine or PBS, and were then intranasally challenged with a mouse-adapted SARS-CoV-2 strain. Clinical scores (A), body weights (B), and virus titers in the lung tissue (C) of mice were recorded. The data are
Jian Shang (1358481) +20 more
core +1 more source
On the Optimisation of Illumination LEDs for VLP Systems
Photonics, 2022 Recent studies have explored the synergy of illumination and positioning using indoor lighting infrastructure. While these studies mainly focused on the analysis of the performance of visible light positioning, these works did not consider the illumination aspects of such combined systems. In this paper, we analyse the illumination aspects based on the
José Miguel Menéndez, Heidi Steendam
openaire +3 more sources
Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
Viruses, 2019 Human cytomegalovirus (HCMV) infects more than 70% of the human population worldwide. HCMV is responsible for high morbidity and mortality in immunocompromised patients and remains the leading viral cause of congenital birth defects. Despite considerable
Michela Perotti, Laurent Perez
doaj +1 more source
RNA: packaged and protected by VLPs
RSC Advances, 2018 VLP packaging is most efficient for compact RNA, and protects RNA against assault by small diffusible damaging agents.
Po-Yu Fang +4 more
openaire +3 more sources
VLPs and particle strategies for cancer vaccines [PDF]
Expert Review of Vaccines, 2013 Effective delivery of tumor antigens to APCs is one of the key steps for eliciting a strong and durable immune response to tumors. Several cancer vaccines have been evaluated in clinical trials, based on soluble peptides, but results have not been fully satisfactory.
UNGARO, FRANCESCA +5 more
openaire +4 more sources
iScienceSummary: Continuing emergence of variants of concern resulting in reduced SARS-CoV-2 vaccine efficacy necessitates additional prevention strategies. The structure of VLPCOV-01, a lipid nanoparticle-encapsulated, self-amplifying RNA COVID-19 vaccine with ...
Masayuki Aboshi +14 more
doaj +1 more source